Assessment of the etiologies and renal outcomes of rapidly progressive glomerulonephritis in pediatric patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

References

1. ↵
   1. Chadban SJ,
   2. Atkins RC

   (2005) Glomerulonephritis. Lancet 365:1797–1806.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Couser WG

   (1993) Pathogenesis of glomerulonephritis. Kidney Int Suppl 42:S19–S26.

   OpenUrlPubMed
3. ↵
   1. McGrogan A,
   2. Franssen CFM,
   3. de Vries CS

   (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26:414–430.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Baldwin DS,
   2. Neugarten J,
   3. Feiner HD,
   4. Gluck M,
   5. Spinowitz B

   (1987) The existence of a protracted course in crescentic ?glomerulonephritis. Kidney Int 31:790–794.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Couser WG

   (1988) Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11:449–484.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Lohr JW

   Medscape, Rapidly Progressive Glomerulonephritis, Epidemiology. Available from: http://emedicine.medscape.com/article/240457-overview#a6. [Accessed June 2016].
7. ↵
   1. Shawarbya M,
   2. Al Tamimia D,
   3. Al Mueilob S,
   4. Saeed I,
   5. Hwiesh A,
   6. Al Muhanna F,
   7. et al.

   (2010) A clinicopathologic study of glomerular disease: Experience of the King Fahd Hospital of the University, Eastern Province, Saudi Arabia. Hong Kong J Nephrol 12:20–30.

   OpenUrl
8. ↵
   1. Zent R,
   2. Van Zyl Smit R,
   3. Duffield M,
   4. Cassidy MJ

   (1994) Crescentic glomerulonephritis at GooteShuur Hospital, South Africa, not a benign disease. Clin Nephrol 42:22–29.

   OpenUrlPubMed
9. ↵
   1. Maslauskiene R,
   2. Urbanaviciene J

   (2003) Rapidly progressive glomerulonephritis syndrome: course, pathomorphology and outcome (data of Kaunas University of Medicine Hospital 1996-2002). Medicina (Kaunas) 39:33–40.

   OpenUrl
10. ↵
    1. Dewan D,
    2. Gulati S,
    3. Sharma RK,
    4. Prasad N,
    5. Jain M,
    6. Gupta A,
    7. et al.

    (2008) Clinical spectrum and outcome of crescentic glomerulonephritis in children in developing countries. Pediatr Nephrol 23:389–394.

    OpenUrlCrossRefPubMed
11. ↵
    1. Sinha A,
    2. Puri K,
    3. Hari P,
    4. Dinda AK,
    5. Bagga A

    (2013) Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr 50:283–288.

    OpenUrl
12. ↵
    1. Alsaad K,
    2. Oudah N,
    3. Al Ameer A,
    4. Fakeeh K,
    5. Al Jomaih A,
    6. Al Sayyari A

    (2011) Glomerulonephritis with crescents in children: etiology and predictors of renal outcome. ISRN Pediatr 2011:507298.

    OpenUrlPubMed
13. ↵
    1. Williams JR

    (2008) The Declaration of Helsinki and public health. Bulletin of the World Health Organization 86:650–652.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents

    (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Avellino GJ,
    2. Bose S,
    3. Wang DS

    (2016) Diagnosis and management of hematuria. Surg Clin North Am 96:503–515.

    OpenUrl
16. ↵
    1. Soler YA,
    2. Nieves-Plaza M,
    3. Prieto M,
    4. García-De Jesús R,
    5. Suárez-Rivera M

    (2013) Pediatric risk, injury, failure, loss, end stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study. Pediatr Crit Care Med 14:e189–e195.

    OpenUrlCrossRefPubMed
17. ↵
    1. Hogg RJ,
    2. Furth S,
    3. Lemley KV,
    4. Portman R,
    5. Schwartz GJ,
    6. Coresh J,
    7. et al.

    (2003) National kidney foundation's kidney disease outcomes quality initiative: clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Koyama A,
    2. Yamagata K,
    3. Makino H,
    4. Arimura Y,
    5. Wada T,
    6. Nitta K,
    7. et al.

    (2009) A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol 13:633–650.

    OpenUrlCrossRefPubMed
19. ↵
    1. Grøndahl C,
    2. Rittig S,
    3. Johan Povlsen JV,
    4. Kamperis K

    (2016) Protracted clinical course of post-infectious glomerulonephritis in a previously healthy child. Case Rep Nephrol Dial 6:70–75.

    OpenUrl
20. ↵
    1. Hogg RJ

    (1985) A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group. Kidney Int 27:450–458.

    OpenUrlCrossRefPubMedWeb of Science
21. 1. Niaudet P,
    2. Levy M

    (1983) Glomerulonephritis a 'croissants diffus. Néphrologie Pédiatrique, 381–994.
22. 1. Jardim H,
    2. Leake J,
    3. Risdon RA,
    4. Barrat M,
    5. Dillon M

    (1992) Crescentic glomerulonephritis in children. Pediatr Nephrol 6:231–235.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. Hedger N,
    2. Stevens J,
    3. Drey N,
    4. Walker S,
    5. Roderick P

    (2000) Incidence and outcome of pauciimmune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant 15:1593–1599.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    1. Özlü SG,
    2. Çaltık A,
    3. Aydoğ Ö,
    4. Bülbül M,
    5. Demircin GE

    (2016) Crescentic glomerulonephritis in children: a single centre experience. World J Pediatr 12:225–230.

    OpenUrl
25. ↵
    1. Schwartzman-Morris J,
    2. Putterman C

    (2012) Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol 2012:604892.

    OpenUrlPubMed
26. ↵
    1. Moroni G,
    2. Ponticelli C

    (2014) Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmun Rev 13:723–739.

    OpenUrlCrossRefPubMed
27. ↵
    1. Greenhall GH,
    2. Salama AD

    (2015) What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J 8:143–150.

    OpenUrlCrossRef